➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKinsey
McKesson
Johnson and Johnson
Dow

Last Updated: April 21, 2021

DrugPatentWatch Database Preview

SODIUM CHLORIDE 0.9% Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Sodium Chloride 0.9%, and what generic alternatives are available?

Sodium Chloride 0.9% is a drug marketed by B Braun, Medefil Inc, Spectra Mdcl Devices, West-ward Pharms Int, Baxter Hlthcare, Abbott, Fresenius Kabi Usa, Fresenius Medcl, Haemonetics, Hospira, Icu Medical Inc, Jubilant Cadista, Laboratorios Grifols, Liebel-flarsheim, Miles, Nephron, and Taro. and is included in thirty-two NDAs.

The generic ingredient in SODIUM CHLORIDE 0.9% is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

Summary for SODIUM CHLORIDE 0.9%
Drug patent expirations by year for SODIUM CHLORIDE 0.9%
Pharmacology for SODIUM CHLORIDE 0.9%

US Patents and Regulatory Information for SODIUM CHLORIDE 0.9%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;IRRIGATION 017427-001 Approved Prior to Jan 1, 1982 AT RX No No   Start Trial   Start Trial   Start Trial
Icu Medical Inc SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 016366-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Baxter Hlthcare SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER sodium chloride SOLUTION FOR SLUSH;IRRIGATION 019319-002 May 17, 1985 RX No No   Start Trial   Start Trial   Start Trial
Hospira SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019465-002 Jul 15, 1985 AP RX Yes No   Start Trial   Start Trial   Start Trial
Jubilant Cadista SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 203352-001 May 18, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
Harvard Business School
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.